TITLE

FDA Faces Challenges Meeting Its Growing Medical Product Responsibilities and Should Develop Complete Estimates of Its Resource Needs

PUB. DATE
July 2009
SOURCE
GAO Reports;7/20/2009, preceding p1
SOURCE TYPE
Government Documents
DOC. TYPE
Article
ABSTRACT
The article reports on the results of an evaluation conducted by the U.S. Government Accountability Office (GAO) on the ability of the Food and Drug Administration (FDA) in meeting its oversight responsibilities on the safety and efficacy of medical products. GAO examined data on the FDA's fiscal year 2004-2008 resources and workload in four key areas. It recommends that the Commissioner of the FDA establish a comprehensive and reliable basis for substantiating the agency's resource needs.
ACCESSION #
43465526

 

Related Articles

  • FDA Needs to Enhance Its Oversight of Drugs Approved on the Basis of Surrogate Endpoints. Crosse, Marcia // GAO Reports;10/26/2009, preceding p1 

    The article focuses on a study by the U.S. Government Accountability Office (GAO) on approved drug applications based on surrogate endpoints under Food and Drug Administration's (FDA) accelerated and traditional approval process and the FDA's oversight of postmarketing studies. FDA is...

  • FDA Update.  // Pharmaceutical Representative;May2010, Vol. 40 Issue 5, p11 

    The article focuses on a report issued by the U.S. Government Accountability Office (GAO) concerning the strategic planning and management of the Food and Drug Administration (FDA).

  • WEEK IN WASHINGTON.  // BioWorld Insight;2/18/2014, Vol. 22 Issue 7, p6 

    The article offers information on the role of the U.S. Food and Drug Administration for missing out the opportunities to mitigate and proactively prevent drug shortages in the U.S., according to the reports of the U.S. Government Accountability Office (GAO).

  • FDA safety effort necessary.  // Medical Marketing & Media;Feb2010, Vol. 45 Issue 2, p10 

    The article reports on the U.S. Government Accountability Office (GAO) study on the need for the Food and Drug Administration (FDA) to develop a comprehensive plan to prepare the Office of Surveillance and Epidemiology (OSE) to take over additional regulatory authorities from the Office of New...

  • FDA Questioned by Other Feds on High-Risk Devices. Reed, Vita // Orange County Business Journal;4/25/2011, Vol. 34 Issue 17, p65 

    The article reports that the approval of U.S. Food and Drug Administration (FDA) to certain high-risk medical devices such as pacemakers and hip joints, has been criticized by the Government Accountability Office (GAO), which states that the high-risk devices are approved without sufficient...

  • FDA panel OKs expanded use for CRT-D.  // Cardiology Today;Jan2012, Vol. 15 Issue 1, p31 

    The article reports on the approval given by a U.S. Food and Drug Administration (FDA) panel to expand the use of Medtronic's cardiac resynchronization therapy defibrillator.

  • FDA panel recommendation creates mixed opinions about future of rosiglitazone. Kalvaitis, Katie // Hem/Onc Today;8/25/2010, Vol. 11 Issue 16, p41 

    This article deals with the questions raised by physicians on the future of rosiglitazone, a diabetic drug, about its future following a recommendation by the U.S. Food and Drug Administration (FDA) advisory committee that it stays on the U.S. market but with revised labeling and restrictions on...

  • FDA issues proposed rule, guidance for drug compounding under DQSA.  // AHA News;7/11/2014, Vol. 50 Issue 14, p2 

    The article reports that the U.S. Food and Drug Administration (FDA) released a proposal to add 25 items to its list of drug products that may not be compounded, a draft interim guidance for facilities that outsource compounded drugs, and a final guidance for entities intending to compound drugs.

  • Heparin Producers on Import Alert. Serebrov, Mari // BioWorld Today;2/27/2012, Vol. 23 Issue 38, p6 

    The article deals with the import alerts imposed by the U.S. Food and Drug Administration (FDA) in February 2012 on heparin and heparin-related products made by certain Chinese firms.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics